Publications

The EAU Research Foundation has published the following publications.

Search in Publications

Zoledronic acid for the prevention of bone metastases in high risk prostate cancer.

Wirth M, Tammela T, Huland H, Gomez Veiga F, Delaere K, Cicalese V, Stenzl A, Bartsch G, Debruyne F, Miller K, Patel A, Torri V, Tubaro A, Witjes W. A randomised, open label, collaborative group study of the European Association of Urology (EAU), the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft Urologische Onkologie (AUO).

Nosocomial urinary tract infections in urology sections.

Bjerklund Johansen TE, Cek M, Naber K, Grabe M, Tenke P. Data from PEP and PEAP Studies.

Effectiveness of zoledronic acid for the prevention of bone metastases in high-risk prostate cancer patients.

Wirth M, Tammela T, Huland H, Cicalese V, Gomez Veiga F, Delaere K, Schulze M, Bartsch G, Debruyne F, Miller K, Patel A, Torri V, Tubaro A, Witjes W. Study design and current enrollment of the Zoledronic Acid European Study (ZEUS).

Effectiveness of zoledronic acid for the prevention of bone metastases in high risk prostate cancer patients.

Witjes W, Tammela T, Wirth M. A randomised, open label, multicenter study of the European Association of Urology (EAU) in Cooperation with the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft Urologische Onkologie (AUO). An initial report of the "ZEUS" study.